Medical Oncology — Medicare Part B billing by state
40 physician groups whose primary specialty is Medical Oncology billed $156.1M to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Nebraska | $27.5M | $27.2M | 2 | $13.6M | 1.6M | 59,476 | 811K |
| Alabama | $27.5M | $26.6M | 2 | $13.3M | 1.5M | 84,832 | 731K |
| Oklahoma | $20.0M | $19.4M | 2 | $9.7M | 1.1M | 58,304 | 564K |
| Pennsylvania | $10.9M | $10.7M | 6 | $1.8M | 808K | 58,676 | 135K |
| Wyoming | $8.7M | $8.9M | 1 | $8.9M | 319K | 17,292 | 319K |
| North Dakota | $8.6M | $8.8M | 1 | $8.8M | 630K | 7,420 | 630K |
| Arizona | $7.5M | $7.5M | 1 | $7.5M | 402K | 14,192 | 402K |
| Massachusetts | $7.3M | $7.8M | 2 | $3.9M | 91,860 | 52,048 | 45,930 |
| California | $6.0M | $6.3M | 5 | $1.3M | 293K | 12,264 | 58,569 |
| New Jersey | $4.9M | $5.1M | 3 | $1.7M | 216K | 7,859 | 72,112 |
| Utah | $4.3M | $4.2M | 1 | $4.2M | 352K | 27,652 | 352K |
| Texas | $4.3M | $4.2M | 4 | $1.1M | 267K | 13,383 | 66,671 |
| Indiana | $3.5M | $3.4M | 2 | $1.7M | 387K | 13,448 | 193K |
| New York | $3.5M | $4.0M | 7 | $567K | 46,474 | 22,450 | 6,639 |
| Tennessee | $3.4M | $3.4M | 2 | $1.7M | 157K | 8,873 | 78,512 |
| Florida | $3.1M | $3.1M | 4 | $778K | 349K | 12,155 | 87,134 |
| Alaska | $3.0M | $3.1M | 2 | $1.5M | 131K | 6,413 | 65,746 |
| Maine | $1.1M | $988K | 2 | $494K | 4,856 | 2,112 | 2,428 |
| Michigan | $365K | $363K | 2 | $182K | 33,337 | 2,015 | 16,668 |
| Ohio | $335K | $326K | 3 | $109K | 5,271 | 3,221 | 1,757 |
| New Hampshire | $145K | $147K | 1 | $147K | 2,239 | 1,240 | 2,239 |
| Connecticut | $119K | $129K | 3 | $43K | 1,622 | 824 | 541 |
| Maryland | $110K | $113K | 3 | $38K | 1,644 | 815 | 548 |
| Colorado | $109K | $110K | 1 | $110K | 1,003 | 475 | 1,003 |
| Minnesota | $91K | $90K | 2 | $45K | 2,900 | 614 | 1,450 |
| District of Columbia | $71K | $69K | 1 | $69K | 1,071 | 657 | 1,071 |
| Rhode Island | $57K | $60K | 1 | $60K | 571 | 347 | 571 |
| Arkansas | $45K | $41K | 1 | $41K | 1,154 | 796 | 1,154 |
| Oregon | $30K | $35K | 1 | $35K | 550 | 212 | 550 |
| Vermont | $6K | $5K | 1 | $5K | 110 | 87 | 110 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
5 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | $43.2M | 983K | NEALOKPAWY |
| J0897 · Injection, denosumab, 1 mg | $10.6M | 522K | NEALOKPAWY |
| J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj | $6.9M | 176K | NEALOKPAWY |
| J9299 · Injection, nivolumab, 1 mg | $5.5M | 226K | NEALOKPAWY |
| G6015 · Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | $3.4M | 12,951 | NEALOKPAWY |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | $1.3M | 1.6M | NEALOKPAWY |
| J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services | $976K | 421K | NEALOKPAWY |
| J0185 · Injection, aprepitant, 1 mg top by services | $353K | 267K | NEALOKPAWY |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | $114K | 419K | NEALOKPAWY |
| J1453 · Injection, fosaprepitant, 1 mg top by services | $47K | 425K | NEALOKPAWY |
| J1756 · Injection, iron sucrose, 1 mg top by services | $42K | 245K | NEALOKPAWY |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $31K | 307K | NEALOKPAWY |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $22K | 247K | NEALOKPAWY |